Cipla Vs Sun Pharmaceutical – Financials, Future Plans & More
Trade Brains
JANUARY 17, 2024
As per the IQVIA report, the global medicine market is expected to reach USD 1.9 trillion by 2027, growing at a CAGR of 3-6% over 2023–2027. Cipla invests in Ethris to collaborate on the development of mRNA-based therapies that can help maximise shareholder value.
Let's personalize your content